Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Nephrology

Genetics, Inheritance, and Subtypes of FRTS

At a Glance

FRTS1 is a genetic kidney disorder caused by a disease-causing GATM variant. It follows autosomal dominant inheritance: a carrier parent has a 50% chance of passing the variant to each child, but symptoms can differ widely among relatives.

While several conditions can cause Fanconi syndrome, Fanconi Renotubular Syndrome 1 (FRTS1) is a specific genetic disorder caused by a mutation in the GATM gene [1]. Understanding the genetics of FRTS1 helps explain why the kidneys become damaged and what this diagnosis means for your family.

The GATM Gene: From Energy to Injury

To understand FRTS1, it helps to look at the GATM gene’s normal job. This gene provides instructions for making an enzyme called glycine amidinotransferase (AGAT) [2].

  • Normal Function: AGAT is the first “worker” in the assembly line that creates creatine, a molecule your body uses to store and move energy, especially in the kidneys and muscles [3][1].
  • The Mutation: In FRTS1, the GATM gene has a mistake (usually a missense variant) that changes how the AGAT protein is shaped [4][1].
  • Proposed Cell Injury: Based on laboratory models and tissue studies, researchers propose that the mutated protein “misfolds” and clumps together inside the mitochondria (the powerhouses of the cell) within the kidney’s proximal tubules [5][6].

These protein clumps act like sand in a delicate engine. They are thought to trigger the production of reactive oxygen species (ROS)—harmful molecules that cause “oxidative stress”—and activate the body’s inflammatory systems [1][7]. Over many years, researchers believe this chronic inflammation can lead to fibrosis (scarring) of the kidney tissue, which may slowly reduce kidney function [4][7]. (Note: There is no routine clinical bedside test for mitochondrial health. Your doctor will monitor your kidneys through established markers like eGFR, blood pressure, and urinalysis).

Understanding Autosomal Dominant Inheritance

FRTS1 follows an autosomal dominant inheritance pattern [4]. This has three important implications for families:

  1. One Copy: A person only needs to inherit one pathogenic copy of the GATM gene (from either parent) to be at risk for the condition [8].
  2. 50% Chance: If a parent carries the pathogenic GATM variant, there is a 50% chance of passing that variant to each child [5].
  3. Variable Expression (Penetrance): Inheriting the variant does not mean inheriting identical symptoms. Expression is highly variable. Some family members may have severe rickets as children, while others with the same mutation may only show mild “leaks” in their urine or unexplained kidney decline in adulthood [4][8].

Because of this variability, doctors often recommend cascade testing—offering genetic testing and clinical screening (like blood and urine tests) to first-degree relatives (parents, siblings, and children) of the person diagnosed [4][5].

Comparing FRTS Subtypes

FRTS1 is just one “flavor” of Fanconi Renotubular Syndrome. Scientists have identified several other subtypes, each caused by a different gene. (Note: The extra-renal features listed below are based on reported cases and can be highly variable). Your medical team used your genetic results to distinguish between these:

Subtype Gene Key Distinguishing Features
FRTS1 GATM Caused by protein clumping in mitochondria; can lead to slow kidney scarring [1].
FRTS2 SLC34A1 Primary issue is phosphate transport; often involves kidney stones or calcium deposits (nephrocalcinosis) [9][10].
FRTS3 EHHADH A “mislocalization” disorder where a protein goes to the wrong part of the cell; can cause mild leaks or rickets [11][12].
FRTS4 HNF4A Very rare; can include Fanconi syndrome along with “MODY” (a form of diabetes) or neonatal blood sugar issues [13][14].
FRTS5 NDUFAF6 Often more severe; can involve both kidney dysfunction and lung issues (pulmonary fibrosis) [15][16].

Knowing you have the GATM-associated form (FRTS1) allows your doctors to focus specifically on monitoring your long-term kidney function, bone health, and urine losses [4][1].

Common questions in this guide

What causes FRTS1 in the kidneys?
FRTS1 is caused by a disease-causing change in GATM, the gene that helps make an enzyme involved in creatine production. Researchers think the altered protein can collect in the energy centers of kidney tubule cells, contributing to cell damage, inflammation, and scarring over time.
How is FRTS1 passed through families?
FRTS1 follows an autosomal dominant pattern, meaning one disease-causing copy of GATM can be enough to place a person at risk. When a parent carries the variant, each child has a 50% chance of inheriting it, although the severity and timing of symptoms can differ.
Can relatives have different FRTS1 symptoms?
Yes. The condition can affect relatives differently: one person may have severe rickets in childhood, while another with the same GATM variant may have mild urine losses or kidney function decline only in adulthood.
Should my family members get genetic testing for FRTS1?
Doctors often offer cascade testing to parents, siblings, and children of a person with FRTS1, along with blood and urine screening. Testing can identify relatives who carry the GATM variant even if they have few or no symptoms, and a genetic counselor can help plan it.
What does a VUS in the GATM gene mean?
A variant of uncertain significance, or VUS, is a change in the GATM gene whose link to FRTS1 is not yet clear. It is not the same as a confirmed disease-causing result, so your genetics team may interpret it using your clinical findings, family testing, and updated evidence.
How are FRTS1 and the other FRTS subtypes different?
FRTS1 is linked to GATM, whereas FRTS2 through FRTS5 are linked to SLC34A1, EHHADH, HNF4A, and NDUFAF6. These subtypes can differ in their associated findings, such as kidney stones, rickets, diabetes or blood-sugar problems, and lung scarring, so the genetic result helps guide monitoring.
What tests monitor FRTS1 over time?
Routine monitoring may include estimated glomerular filtration rate (eGFR), blood pressure, and urinalysis to track kidney health and urine losses. Your healthcare team may also monitor bone health because rickets and other bone effects can occur.

Get notified when new evidence is published on Fanconi renotubular syndrome 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Glycine Amidinotransferase (GATM), Renal Fanconi Syndrome, and Kidney Failure.

    Reichold M, Klootwijk ED, Reinders J, et al.

    Journal of the American Society of Nephrology : JASN 2018; (29(7)):1849-1858 doi:10.1681/ASN.2017111179.

    PMID: 29654216
  2. 2

    Creatine maintains intestinal homeostasis and protects against colitis.

    Turer E, McAlpine W, Wang KW, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2017; (114(7)):E1273-E1281 doi:10.1073/pnas.1621400114.

    PMID: 28137860
  3. 3

    Creatine biosynthesis and transport in health and disease.

    Joncquel-Chevalier Curt M, Voicu PM, Fontaine M, et al.

    Biochimie 2015; (119()):146-65.

    PMID: 26542286
  4. 4

    Genetic Screening of Patients With Inherited Fanconi Syndrome.

    Inoki Y, Sakakibara N, Yamamoto A, et al.

    Kidney international reports 2026; (11(7)):106576 doi:10.1016/j.ekir.2026.106576.

    PMID: 42282999
  5. 5

    Complex phenotype in Fanconi renotubular syndrome type 1: Hypophosphatemic rickets as the predominant presentation.

    Li CY, Sun Y, Guo WC, et al.

    Clinica chimica acta; international journal of clinical chemistry 2024; (561()):119812 doi:10.1016/j.cca.2024.119812.

    PMID: 38876250
  6. 6

    Functional Analysis of a Novel Pathogenic Glycine Amidinotransferase Mutant in Hereditary Fanconi Syndrome.

    Takayanagi S, Mori KP, Kang Y, et al.

    Kidney medicine 2026; (8(3)):101267 doi:10.1016/j.xkme.2026.101267.

    PMID: 41783431
  7. 7

    Distinct Mitochondrial Pathologies Caused by Mutations of the Proximal Tubular Enzymes EHHADH and GATM.

    Forst AL, Reichold M, Kleta R, Warth R

    Frontiers in physiology 2021; (12()):715485 doi:10.3389/fphys.2021.715485.

    PMID: 34349672
  8. 8

    Renal proteomic landscape of a patient with Fanconi renotubular syndrome carrying a novel GATM variant.

    Lu F, Yang L, Qian S, et al.

    Frontiers in physiology 2026; (17()):1921122 doi:10.3389/fphys.2026.1921122.

    PMID: 42845598
  9. 9

    Clinical Heterogeneity and Phenotypic Expansion of NaPi-IIa-Associated Disease.

    Demir K, Yildiz M, Bahat H, et al.

    The Journal of clinical endocrinology and metabolism 2017; (102(12)):4604-4614 doi:10.1210/jc.2017-01592.

    PMID: 29029121
  10. 10

    Targeting Hypercalciuria in SLC34A1-Related Disorders: Impact of Oral Phosphate Therapy and Novel Genetic Insights in Pediatric Case Series.

    Turan I, Atar M, Eltan M, et al.

    Calcified tissue international 2026; (117(1)):10 doi:10.1007/s00223-025-01462-x.

    PMID: 41543768
  11. 11

    Renal Fanconi Syndrome Is Caused by a Mistargeting-Based Mitochondriopathy.

    Assmann N, Dettmer K, Simbuerger JMB, et al.

    Cell reports 2016; (15(7)):1423-1429 doi:10.1016/j.celrep.2016.04.037.

    PMID: 27160910
  12. 12

    A puzzling renal Fanconi syndrome.

    Haydock L, Hureaux M, Hoffmann M, et al.

    Clinical kidney journal 2025; (18(8)):sfae408 doi:10.1093/ckj/sfae408.

    PMID: 40800210
  13. 13

    Phenotypic Spectrum of HNF4α-Associated Fanconi Renotubular Syndrome.

    Emma F, Böckenhauer D, Mallett AJ, et al.

    Kidney international reports 2026; (11(8)):106616 doi:10.1016/j.ekir.2026.106616.

    PMID: 42440446
  14. 14

    Hnf4a Is Required for the Development of Cdh6-Expressing Progenitors into Proximal Tubules in the Mouse Kidney.

    Marable SS, Chung E, Park JS

    Journal of the American Society of Nephrology : JASN 2020; (31(11)):2543-2558 doi:10.1681/ASN.2020020184.

    PMID: 32764140
  15. 15

    Acadian variant of Fanconi syndrome is caused by mitochondrial respiratory chain complex I deficiency due to a non-coding mutation in complex I assembly factor NDUFAF6.

    Hartmannová H, Piherová L, Tauchmannová K, et al.

    Human molecular genetics 2016; (25(18)):4062-4079 doi:10.1093/hmg/ddw245.

    PMID: 27466185
  16. 16

    Unusual Variants in NDUFAF6-Associated Mitochondrial Disease.

    Aoyama Y, Grafstein J, Houston P, et al.

    Rare (Amsterdam, Netherlands) 2026; (5()) doi:10.1016/j.rare.2026.100129.

    PMID: 42683144

This page is for informational purposes only and does not constitute medical advice. A healthcare professional or genetic counselor should interpret your GATM result, testing options, and family risk.